BSECompany Update6d ago · 1 Aug 2026, 06:57 pm

Intimation of Approval for addition of Beds to the Existing Approved Bioavailability/ Bioequivalence Center of Jeevan Scientific Technology Limited''s Bioavailability/ Bioequivalence Study ....

Jeevan Scientific Technology Ltd · 538837

✦ AI Summary▲ PositiveExpansion

Jeevan Scientific Technology Ltd has received approval from CDSCO to increase the bed capacity of its existing Bioavailability/Bioequivalence Study Centre from 132 and 06 ICU beds to 156 and 08 ICU beds.

Analysis Scores

Earnings Impact6/10
Growth Catalyst8/10
Governance Concern1/10
Regulatory Risk2/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment7/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Jeevan Scientific Technology Ltd - 538837 - Intimation Of Approval For Addition Of Beds To The Existing Approved Bioavailability/ Bioequivalence Center Of Jeevan Scientific Technology Limited''s Bioavailability/Bioequivalence.

Attachments (1)

📄

84e067d5-0dcc-4924-bca3-72242431ee57.pdf

pdf

Download →
View document text
f Jeevan Scientific Technology Limited Ref: JSTL/BOD/BSE/2026-27/ AUG26 Date: August 01, 2026 The Manager BSE Limited P. J. Towers, Dalal Street Mumbai-400001. Dear Sir/Madam, Unit: Jeevan Scientific Technology Limited (Scrip Code: 538837) Sub: Intimation of Approval for addition of Beds to the Existing Approved Bioavailability/Bioequivalence Center of Jeevan Scientific Technology Limited's Bioavailability/Bioequivalence Study Center, located at Plot No. B- 17, TIE Phase II, Balanagar, Hyderabad-500037, India Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform the Exchange that the Central Drugs Standard Control Organization (CDSCO) has granted approval for the increase in the bed capacity from 132 and 06 ICU beds to 156 and 08 ICU beds of the Company's existing approved Bioavailability/Bioequivalence (BA/BE) Study Centre situated at Plot No. B-17, TIE Phase 1I, Balanagar, Hyderabad - 500037, Telangana, India. The approval has been granted pursuant to the successful completion of the regulatory inspection conducted by the CDSCO on June 24, 2026 and the Company's application seeking enhancement of the bed capacity at the said BA/BE Study Centre. The increased bed capacity will strengthen the Company's clinical research infrastructure, enhance its operational capabilities, and enable it to undertake a higher volume of Bioavailability/Bioequivalence studies, thereby supporting future business growth. The Company remains committed to maintaining the highest standards of quality, regulatory compliance, and patient safety in all its clinical research operations. This is for your information and record. Yours faithfully, For Jeevan Scientific Technology Limited Krishna Sainadh Kodati Company Secretary & Compliance Officer Registered Office: Plot No. 1&2, Sai Krupa Enclave, Near Lanco Hills, Golconda Post, Hyderabad- 500 008, T.S., India. Tel: +91-40-67364700 Email: info@jeevanscientific.com Web: www. jeevanscientific.com CIN: L72200TG1999PLC031016